Effect of Mosapride on Gut Transit in Patients With Chronic Constipation or Constipated Irritable Bowel Syndrome and Healthy Subjects

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-05-31

Study Completion Date

2016-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Effect of mosapride 30mg/day on the small bowel and colon transit time in patients with chronic constipation or constipated irritable bowel syndrome.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of Mosapride Citrate on Gastrointestinal Motility After Laparoscopic Gastrectomy

NCT04493125

Stomach Cancer

COMPLETED NA

Randomized Trial of Mosapride Versus Placebo in the Treatment of Constipation-Predominant Irritable Bowel Syndrome

NCT00742872

Constipation-Predominant Irritable Bowel Syndrome

TERMINATED PHASE3

Efficacy of Mosapride on Recovery of Intestinal Motility After Elective Colorectal Cancer Surgery

NCT04905147

Colorectal Cancer Bowel Ileus

UNKNOWN NA

Trial to Evaluate the Efficacy and Safety of R093877 in Patients With Chronic Idiopathic Constipation

NCT00596596

Constipation

COMPLETED PHASE2

An Observational Study to Evaluate the Quality of Life in Korean Female Participants With Chronic Constipation

NCT01902537

Constipation

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Constipated Irritable Bowel Syndrome Chronic Constipation Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

mosapride

Group Type EXPERIMENTAL

Mosapride

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mosapride

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Functional constipation or constipated irritable bowel syndrome patients according to Rome III criteria

Exclusion Criteria

* Intolerable or hypersensitive to mosapride
* Known Parkinson's ds
* Cardio- or cerebrovascular disease within 3 months
* Malignancy requiring surgery or chemotherapy or radiation within 5 years
* History of GI surgeries except hernia repair, appendectomy, primary closure due to perforation
* Refractory diabetes mellitus/hypertension/thyroid diseases
* Symptomatic heart failure, renal failure, arrhythmia

Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No